Ray Dalio Commentary- The Determinants: On Inflation and Wealth
Yesterday’s inflation report showed inflation raging so you are now seeing inflation erode your wealth. That is no surprise. At…
SPY,DJI,QQQ
GMO Commentary: 3Q 2021 Market Commentary
Global equity markets were a bit herky-jerky on the quarter. A strong rally characterized the early part of the summer…
Royce Investment Partners- The Undiscovered Connection: Value-Led Periods and Active Management
In our research into small-cap performance patterns, we uncovered a connection that we believe is significant. There seems to be…
GMO Commentary: Learning to Live With Covid-19
Last year we invested in selected companies that we judged would benefit from the reopening of the global economy, so…
Causeway- Don’t Fear the Fed: The Impact of Monetary Tightening on Emerging Markets Equities
Based on the Federal Open Market Committee’s September policy statement, it seems increasingly likely that the U.S. Federal Reserve (“Fed”)…
GMO Commentary- LDI: The Bespoke Benefit
Overview Liability-Driven Investing requires dynamic solutions to meet clients’ evolving needs over time. In this discussion, portfolio manager and fixed…
Royce Investment Partners: 3Q21 Small-Cap Recap
In 3Q21, Bigger was Better 2021’s third quarter saw the first negative return quarter for the small-cap Russell 2000 Index…
Is It Time for Investors to Take a More Cautious Stance?
In the Federal Reserve’s Wednesday meeting, officials indicated they expect to begin reducing monthly asset purchases “soon,” though they did…
William Blair Commentary: Why Industrials Can Be ‘Growth’ Stocks
Our overweight to industrials is unique for growth investors, but there are good reasons for it. These companies offer high…
Jeremy Grantham’s GMO 2nd-Quarter Letter: Dispelling Myths in the Value Vs. Growth Debate
Executive Summary After several strong quarters for value stocks, the last few months have seen a sharp reversal in favor…
